Tag: actinic keratosis market share

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Actinic Keratosis Market Expected To Grow In Terms Of Size?

The market for actinic keratosis has been on a steady rise in the years past. It’s set to expand from $7.95 billion in 2024 to $8.42 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. Several factors contribute to this growth during the historic period. These include heightened exposure to UV radiation, an aging population, increased knowledge about skin cancer, a growing number of actinic keratosis cases, an expanding healthcare sector, higher disposable income levels, supportive government initiatives, and an increasing emphasis on preventive skincare.

The market for actinic keratosis is projected to experience substantial growth in the upcoming years, escalating to a $10.5 billion valuation in 2029, reflecting a compound annual growth rate (CAGR) of 5.7%. Several factors contribute to this expansion during the forecasted period which include innovative therapeutic introductions, improvements in AI-driven diagnostic devices, the increasing preference for combination therapies, the surge in demand for non-invasive procedures and the expansion of tele dermatology. Other factors include the growing utilization of photodynamic treatment, heightened consciousness about aesthetic outcomes, the arrival of specialized biological treatments, ballooning healthcare investment in emerging markets and heightened emphasis on preventative care and early detection. Key trends during the forecasted period consist of AI-powered diagnostic tools, the use of machine learning in lesion analysis, state-of-the-art photodynamic therapy systems, wearable devices for UV radiation monitoring, nanotechnology utilized in drug delivery, 3D imaging for tailored treatments, user-friendly home-based phototherapy devices, biosensors for early detection, software for automated lesion classification, and therapeutic systems based on hydrogel.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

Which Key Factors Are Fueling Growth In The Actinic Keratosis Market?

The surge in severe sunburn cases is poised to fuel the expansion of the actinic keratosis market in the near future. Severe sunburns, intense skin injuries resulting from excess exposure to UV radiation, cause symptoms like redness, pain, swelling, and sometimes even blistering. Factors such as extended exposure to UV radiation, inadequate sun protection, heightened outdoor activities during peak UV times and increasing temperatures due to global warming contribute to sunburns. Sunburns lead to actinic keratosis by harming the DNA of skin cells via UV radiation, causing mutations that interfere with normal cell operation and giving rise to precancerous lesions, particularly with repeated or extended exposure to the sun. For example, Melanoma Focus, a UK charity, reported in May 2024 that in the year 2022-23, there were 201 hospital admissions due to sunburn, including 89 children and 25 infants under one year old. The charity also discovered that 66% of UK adults between the ages of 16-65 recalled being sunburned as children, and 65% had suffered a severe sunburn with at least one instance of blistering. This figure increased to 77% for individuals with light, pale or white skin. Consequently, the rising instances of severe sunburns are stimulating the growth of the actinic keratosis market.

How Is The Actinic Keratosis Market Categorized Across Applications And Types?

The actinic keratosismarket covered in this report is segmented –

1) By Treatment Type: Topical Treatment; Surgical Procedure; Photodynamic Therapy; Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers

3) By End-User: Hospitals; Dermatology Clinics; Spas And Rejuvenation Centers; Homecare Settings; Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU); Imiquimod; Diclofenac; Ingenol Mebutate; Retinoids

2) By Surgical Procedure: Cryotherapy; Curettage And Electrodessication; Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy; Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy; Chemical Peels; Combination Therapies

How Are Industry Trends Steering The Expansion Of The Actinic Keratosis Market?

Prominent businesses in the actinic keratosis market are focusing on the creation of topical ointments aimed at effectively addressing and eradicating precancerous lesions while reducing recurrence percentages and improving patient adherence with shorter treatment periods and better safety measures. Active ingredients such as tirbanibulin are incorporated in these topical ointments, which are therapeutic creams or gels directly placed on the affected skin; these target abnormal keratinocytes to address precancerous lesions. For instance, Almirall SA, a biopharmaceutical firm based in Spain, gained approval from the US Food and Drug Administration (FDA) in June 2024 for a supplemental new drug application (sNDA) to increase the usage area of its drug, Klisyri, to as much as 100 cm2. Klisyri (tirbanibulin) 1% ointment, a microtubule inhibitor, is engineered to halt the growth of abnormal keratinocytes, thus significantly diminishing the count and magnitude of precancerous lesions in the treatment of actinic keratosis (AK) on the face or scalp.

Which Firms Are Making The Biggest Impact In The Actinic Keratosis Market?

Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Region Holds The Greatest Opportunity For Actinic Keratosis Market Expansion?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Browse Through More Reports Similar to the Global Actinic Keratosis Market 2025, By The Business Research Company

Actinic Keratosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-treatment-global-market-report

Natural Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Actinic Keratosis Market Between 2025 And 2029?

The actinic keratosis market has demonstrated significant expansion in recent years. It is anticipated to grow from $7.95 billion in 2024 to $8.42 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.8%. This growth observed in the past can be attributed to increased UV radiation exposure, an aging demographic, heightened awareness of skin cancer, the rising incidence of actinic keratosis, developing healthcare infrastructure, higher disposable incomes, supportive government initiatives, and a greater focus on preventive skincare.

The actinic keratosis market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $10.5 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.7%. This forecasted growth is primarily driven by several factors, including the introduction of novel therapies, progress in AI-driven diagnostic instruments, wider acceptance of combination treatment approaches, a surge in demand for non-invasive interventions, increased utilization of teledermatology services, broadened application of photodynamic therapy, heightened public understanding of cosmetic results, the creation of specific biologic treatments, increasing healthcare funding in developing economies, and an intensified emphasis on early diagnosis and preventative measures. Key developments expected during this period encompass AI-powered diagnostic solutions, the application of machine learning for analyzing lesions, sophisticated photodynamic therapy systems, wearable UV monitoring gadgets, drug delivery methods utilizing nanotechnology, 3D imaging for customized therapies, convenient home phototherapy equipment, biosensors designed for early detection, automated software for classifying lesions, and therapeutic systems based on hydrogels.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

Which Drivers Are Impacting The Actinic Keratosis Market?

A rise in severe sunburn incidents is projected to fuel the expansion of the actinic keratosis market moving ahead. These severe sunburns are characterized as significant skin burns resulting from excessive exposure to ultraviolet (UV) radiation, leading to symptoms such as redness, pain, swelling, and occasionally blisters. Factors contributing to sunburns include extended exposure to ultraviolet (UV) radiation, insufficient sun protection, more outdoor pursuits during intense UV periods, and escalating temperatures linked to climate change. Sunburns contribute to actinic keratosis by inflicting DNA damage in skin cells via ultraviolet (UV) radiation, which in turn causes mutations that interfere with normal cellular function, ultimately fostering the formation of precancerous lesions, particularly with repeated or extensive sun exposure. For example, in May 2024, a report by Melanoma Focus, a charity based in the UK, indicated that during 2022-23, 201 hospital admissions were attributed to sunburns, among them 89 children and 25 infants under the age of one year. The same charity also uncovered that 66% of UK adults aged 16-65 recalled having sunburns in their childhood, with 65% of these individuals experiencing severe sunburns involving blisters on at least one occasion. This figure increased to 77% for individuals possessing light, pale, or white skin tones. Consequently, the escalating incidence of severe sunburns is propelling the expansion of the actinic keratosis market.

How Is The Actinic Keratosis Market Classified Into Different Segments?

The actinic keratosismarket covered in this report is segmented –

1) By Treatment Type: Topical Treatment; Surgical Procedure; Photodynamic Therapy; Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers

3) By End-User: Hospitals; Dermatology Clinics; Spas And Rejuvenation Centers; Homecare Settings; Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU); Imiquimod; Diclofenac; Ingenol Mebutate; Retinoids

2) By Surgical Procedure: Cryotherapy; Curettage And Electrodessication; Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy; Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy; Chemical Peels; Combination Therapies

What Are The Major Trends Driving The Growth Of The Actinic Keratosis Market?

Major companies within the actinic keratosis market are prioritizing the development of topical ointments to effectively target and eliminate precancerous lesions, reduce recurrence rates, and enhance patient compliance through shorter treatment durations and improved safety profiles. These topical ointments are medicated creams or gels applied directly to the affected skin, featuring active ingredients such as tirbanibulin, which function by targeting abnormal keratinocytes to address precancerous lesions. For instance, in June 2024, Almirall SA, a Spain-based biopharmaceutical company, secured approval from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) to broaden the use area for its drug, Klisyri, to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment is a microtubule inhibitor, specifically formulated to prevent the proliferation of abnormal keratinocytes, thereby effectively reducing the number and size of precancerous lesions for the treatment of actinic keratosis (AK) on the face or scalp.

Which Leading Players Are Enhancing Their Actinic Keratosis Market Presence Worldwide?

Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Actinic Keratosis Market?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Actinic Keratosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Browse Through More Reports Similar to the Global Actinic Keratosis Market 2025, By The Business Research Company

Actinic Keratosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-treatment-global-market-report

Natural Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Actinic Keratosis Market Size From 2025 to 2034?

The market size for actinic keratosis has seen robust growth lately. It’s expected to expand from $7.95 billion in 2024 to $8.42 billion in 2025, generating a compound annual growth rate (CAGR) of 5.8%. This historic growth can be linked to factors such as an increase in UV radiation exposure, a growing elderly population, heightened awareness about skin cancer, a rising number of actinic keratosis cases, growth in healthcare infrastructure, increased disposable incomes, governmental support and prevention-focused skincare initiatives.

In the coming years, the actinic keratosis market is poised for robust growth, and it’s anticipated to reach$10.5 billion in 2029 with a compound annual growth rate (CAGR) of 5.7%. The growth factors during the predicted period include the development of ground-breaking treatments, progress in AI-empowered diagnostic tools, a surge in the acceptance of comprehensive therapies, increased interest in non-invasive methods, an expanding use of tele dermatology, a larger use of photodynamic therapy, enhanced cosmetic outcome awareness, the establishment of targeted biologic treatments, a rising investment in healthcare in emergent markets and a shift towards early detection and prevention. Noteworthy trends in the forecast period include diagnostic tools accelerated by AI, lesion analysis through machine learning, sophisticated photodynamic therapy systems, wearable UV monitoring gadgets, nanotechnology-oriented drug delivery, 3D imaging for individualized treatments, transportable home-based phototherapy tools, early detection biosensors, automated lesion categorization software, and hydrogel-infused therapeutic systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

What External and Internal Drivers Are Contributing to the Growth of theActinic Keratosis Market?

The actinic keratosis market is set to thrive due to an uptick in severe sunburn incidences. Severe sunburns, a kind of acute skin burn brought about by overexposure to ultraviolet (UV) radiation results in symptoms like redness, swelling, pain, and potentially blisters. These sunburns are typically caused by prolonged UV exposure, inadequate sun protection, increased outdoor activities at peak UV hours and heightened temperatures attributed to climate change. Actinic keratosis arises from sunburns damaging skin cells’ DNA via UV radiation, leading to mutations that interrupt the normal functioning of cells. This eventually results in the formation of pre-cancerous lesions, especially with extended or repeated sun exposure. Case in point, Melanoma Focus, a UK charity, stated in May 2024 that in the span of 2022-23, 201 hospital admissions were due to sunburn, involving 89 children and 25 babies under one year old. The charity further discovered that 66% of UK adults aged 16-65 recollected being sunburnt as kids, with 65% of them having experienced severe blisters due to sunburn at least once. This figure increased to 77% for individuals with light, pale, or white skin. Hence, the escalation in severe sunburn cases is bolstering the actinic keratosis market’s growth.

What Segment Types Define the Actinic Keratosis Market Structure?

The actinic keratosismarket covered in this report is segmented –

1) By Treatment Type: Topical Treatment; Surgical Procedure; Photodynamic Therapy; Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers

3) By End-User: Hospitals; Dermatology Clinics; Spas And Rejuvenation Centers; Homecare Settings; Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU); Imiquimod; Diclofenac; Ingenol Mebutate; Retinoids

2) By Surgical Procedure: Cryotherapy; Curettage And Electrodessication; Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy; Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy; Chemical Peels; Combination Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Actinic Keratosis Market?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Actinic Keratosis Market?

Major players in the actinic keratosis market are concentrating their efforts on innovating topical ointments. The goal is to successfully target and eradicate precancerous lesions, decrease the likelihood of reoccurrence, and increase patient satisfaction by reducing the length of treatment and improving safety profiles. These topical ointments are medicated gels or creams that are applied to the impacted skin, consisting of active components like tirbanibulin that target abnormal keratinocytes and treat precancerous lesions. For example, in June 2024, Almirall SA, a biopharmaceutical company based in Spain, received approval from the US Food and Drug Administration (FDA) for supplemental new drug application (sNDA) to increase its drug, Klisyri, usage area to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment, a microtubule inhibitor, is intended to hinder the growth of abnormal keratinocytes, hence effectively reducing the quantity and size of precancerous lesions in treating actinic keratosis (AK) on the face or scalp.

View the full report here:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

What Is the Definition of the Actinic Keratosis Market?

Actinic keratosis (AK), also known as solar keratosis, is a common precancerous skin condition that occurs due to prolonged exposure to ultraviolet (UV) radiation from the sun or artificial sources leading to rough, scaly or crusty patches on sun-exposed areas of the skin such as the face, scalp, hands and arms. It is considered an early stage of squamous cell carcinoma (SCC) and requires treatment to prevent progression. Regular skin checks and protection from sun exposure are essential for managing and preventing the development of actinic keratosis.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Actinic Keratosis Market from 2024 to 2025?

The market scale of actinic keratosis has seen a stable increase in previous years. It’s projected to rise from $7.95 billion in 2024 to $8.44 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth during the history period include heightened exposure to UV rays, an aging population, heightened awareness about skin cancer, a growing incidence rate of actinic keratosis, expanded healthcare infrastructure, increased disposable incomes, supportive government schemes, and a heightened emphasis on preventative skincare.

What Is the Projected Market Size of the Actinic Keratosis Market?

Growth is predicted to explode in the actinic keratosis market over the coming years, reaching a valuation of $10.58 billion in 2029 with a compound annual growth rate (CAGR) of 7.4%. This predicted expansion during the forecasted period can be linked to various factors including the introduction of innovative therapies, AI-driven diagnostic tool advancements, the increased uptake of combination treatments, and a growing demand for non-intrusive procedures. A rise in tele dermatology use, the increasing use of photodynamic therapy, heightened awareness around cosmetic results, development of targeted biologic treatments, increased investment in healthcare within emerging markets, and a stronger emphasis on early detection and prevention are also contributing factors in this growth. Looking at the trends during the forecast period, the prominence of AI-powered diagnostic tools, machine-learning-enabled lesion analysis, advanced systems for photodynamic therapy, wearable UV monitors, nanotechnology-oriented drug delivery, 3D imaging for personalized treatments, home-based portable phototherapy devices, early detection biosensors, automated software for lesion classification, and therapeutic systems based on hydrogel are expected to take the lead.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

Who are the Major Competitors in the Actinic Keratosis Market Outlook?

Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.

What Is Fueling Growth in the Actinic Keratosis Market?

The upward trend in extreme sunburn cases is predicted to drive the expansion of the actinic keratosis market. Extreme sunburns involve severe skin damage brought on by excessive ultraviolet (UV) radiation exposure, leading to symptoms such as redness, pain, swelling and sometimes, blisters. Factors contributing to sunburns include sustained UV radiation exposure, failure to take adequate sun protection precautions, escalating outdoor activities during periods of peak UV exposure and rising temperatures induced by climate change. Sunburn-induced actinic keratosis occurs through UV radiation damaging skin cell DNA, causing mutations that interfere with regular cellular function and manifesting in precancerous lesions, especially when the skin is repeatedly or enduringly exposed to the sun. For example, the Melanoma Focus, a charity organization in the UK, reported in May 2024 that in 2022-23, sunburn resulted in 201 hospital admissions, with 89 of the patients being children and 25, babies under the age of one. The charity further revealed that 66% of UK adults between the ages of 16-65 recalled instances of sunburn as children, and 65% of them had suffered at least one episode of extreme sunburn with blisters. This proportion increased to 77% among those with light, pale or white complexion. Hence, the escalating instance of severe sunburns is fuelling the actinic keratosis market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Which Actinic Keratosis Market Segments Are Growing the Fastest?

The actinic keratosis market covered in this report is segmented –

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

3) By End-User: Hospitals, Dermatology Clinics, Spas And Rejuvenation Centers, Homecare Settings, Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac, Ingenol Mebutate, Retinoids

2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication, Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy, Chemical Peels, Combination Therapies

Which Industry Trends Are Shaping the Future of the Actinic Keratosis Market?

The focus of major players in the actinic keratosis market is on the creation of topical ointments that can efficiently target and eliminate precancerous lesions, diminish recurrences, and boost patient adherence through reduced treatment periods and better safety profiles. These topical creams or gels employ an active ingredient such as tirbanibulin to directly treat the affected skin, targeting abnormal keratinocytes that cause precancerous lesions. An example of this is Almirall SA, a biopharmaceutical firm from Spain, which in June 2024, received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) to broaden the utilization of its drug, Klisyri, up to 100 cm2. Klisyri (tirbanibulin) 1% ointment acts as a microtubule inhibitor, preventing the growth of abnormal keratinocytes and effectively reducing the number and size of precancerous lesions for the treatment of actinic keratosis (AK) on the face or scalp.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Countries Are Leading the Actinic Keratosis Market?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077

This Report Delivers Insight On:

1. How big is the actinic keratosis market, and how is it changing globally?

2. Who are the major companies in the actinic keratosis market, and how are they performing?

3. What are the key opportunities and risks in the actinic keratosis market right now?

4. Which products or customer segments are growing the most in the actinic keratosis market?

5. What factors are helping or slowing down the growth of the actinic keratosis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Are the Projected Market Size and Growth Rates for the Actinic Keratosis Market From 2025 To 2029?

The market size for actinic keratosis has experienced a consistent increase over recent years. The market, estimated at $7.95 billion in 2024, is projected to expand to $8.44 billion in 2025, following a compound annual growth rate (CAGR) of 6.1%. The expansion witnessed in the past years has been driven by factors such as escalating exposure to UV radiations, an aging demographic, heightened awareness relating to skin cancer, and the rising incidence of actinic keratosis. Also contributing to the growth are an enhanced healthcare infrastructure, higher disposable incomes, proactive government interventions, and a growing emphasis on preventive skincare.

The market size of actinic keratosis is anticipated to witness substantial growth in the upcoming years, escalating to $10.58 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. Factors such as the advent of inventive therapies, advancements in AI-powered diagnostic instruments, the rising popularity of combination treatments, increased demand for non-invasive procedures, the growing utility of teledermatology, broadening use of photodynamic therapy, heightened awareness of aesthetic outcomes, development of targeted biological treatments, escalating healthcare investment in expanding markets, and an increasing emphasis on early detection and prevention are largely contributing to the growth in the prediction period. Notable trends in the forecast period comprise AI-based diagnostic tools, machine learning for lesion examination, advanced photodynamic therapy systems, wearable UV tracking devices, nanotech-derived drug delivery, 3D imaging for customized treatments, portable phototherapy devices for home use, early detection biosensors, automated software for lesion classification, and hydrogel-based therapeutic systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Actinic Keratosis Market?

The rise in serious sunburn cases is set to boost the expansion of the actinic keratosis market. Serious sunburns, instigated by excessive exposure to ultraviolet (UV) radiation, cause intense skin damage, resulting in redness, pain, inflammation, and possible blistering. These sunburns can be attributed to factors such as extended exposure to UV radiation, inadequate sun protection procedures, increased outdoor activities during peak UV hours and temperatures escalating due to climate change. They can lead to actinic keratosis by disrupting the DNA in skin cells via UV radiation, subsequently causing mutations that impede regular cell activity and lead to the emergence of precancerous lesions, particularly with constant or prolonged sun exposure. As an example, in May 2024, Melanoma Focus, a charity in the UK, reported that in 2022-23 there were 201 hospitalizations because of sunburn, which included 89 children and 25 infants less than a year old. The charity also revealed that 66% of UK adults aged between 16-65 recalled being sunburned in their childhood, with 65% enduring serious sunburn and developing blisters at least once. For those with light, pale, or white skin, this figure escalated to 77%. Consequently, the persistent rise in severe sunburn cases is fuelling the actinic keratosis market’s growth.

Which Key Market Segments Comprise the Actinic Keratosis Market and Drive Its Revenue Growth?

The actinic keratosis market covered in this report is segmented –

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

3) By End-User: Hospitals, Dermatology Clinics, Spas And Rejuvenation Centers, Homecare Settings, Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac, Ingenol Mebutate, Retinoids

2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication, Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy, Chemical Peels, Combination Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Which Areas Are Leading Regions in the Actinic Keratosis Market Expansion Across the Globe?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theActinic Keratosis Market Over the Coming Years?

Prominent enterprises in the actinic keratosis market are concentrating their efforts on producing topical ointments, aiming to effectively assail and eradicate precancerous lesions, slash recurrence occurrences, and boost patient adherence with briefer treatment periods and enhanced safety standards. These topical ointments are medicinal creams or gels, that are applied to the affected skin area, with the active component, such as tirbanibulin, that acts by aiming at abnormal keratinocytes to address precancerous lesions. For example, in June 2024, Almirall SA, a biopharmaceutical corporation based in Spain, obtained the US Food and Drug Administration’s (FDA) approval for a supplemental new drug application (sNDA) to broaden the applicability of its drug Klisyri, to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment is a microtubule inhibitor, created to halt the growth of abnormal keratinocytes, thus effectively diminishing the number and dimensions of precancerous lesions for the remediation of actinic keratosis (AK) on the face or scalp.

View the full report here:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

How Is the Actinic Keratosis Market Conceptually Defined?

Actinic keratosis (AK), also known as solar keratosis, is a common precancerous skin condition that occurs due to prolonged exposure to ultraviolet (UV) radiation from the sun or artificial sources leading to rough, scaly or crusty patches on sun-exposed areas of the skin such as the face, scalp, hands and arms. It is considered an early stage of squamous cell carcinoma (SCC) and requires treatment to prevent progression. Regular skin checks and protection from sun exposure are essential for managing and preventing the development of actinic keratosis.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Actinic Keratosis Market?

The rising incidence of severe sunburns is expected to accelerate the growth of the actinic keratosis market. Severe sunburns result from excessive exposure to ultraviolet (UV) radiation, causing redness, pain, swelling, and sometimes blistering. Factors such as prolonged UV exposure, inadequate sun protection, increased outdoor activities during peak UV hours, and climate change-induced temperature rises contribute to sunburn cases. Sunburns can lead to actinic keratosis by causing DNA damage in skin cells through UV radiation, leading to mutations that interfere with normal cell function and contribute to the formation of precancerous lesions, especially after repeated sun exposure. For instance, in May 2024, Melanoma Focus, a UK-based charity, reported that in 2022-23, there were 201 hospital admissions due to sunburn, including 89 children and 25 infants under one year old. Additionally, 66% of UK adults aged 16-65 recalled experiencing sunburn during childhood, with 65% suffering from severe sunburn with blisters at least once. This number increased to 77% for individuals with light, pale, or white skin. Therefore, the rising incidence of severe sunburns is driving the actinic keratosis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

What is the Predicted Annual Growth Rate of theActinic Keratosis Market Impact Industry Trends by 2034?

The actinic keratosis market has seen consistent growth over the years. It is projected to grow from $7.95 billion in 2024 to $8.44 billion in 2025, at a CAGR of 6.1%. The key factors behind this historical growth include increased exposure to UV radiation, an aging population, greater awareness of skin cancer, a rising prevalence of actinic keratosis, improved healthcare infrastructure, higher disposable incomes, government initiatives, and an increased focus on preventive skincare.

The actinic keratosis market size is anticipated to witness substantial growth in the upcoming years. By 2029, it is projected to reach $10.58 billion, growing at a compound annual growth rate (CAGR) of 7.4%. The expected growth is fueled by the emergence of advanced therapies, improvements in AI-powered diagnostic tools, a rising adoption of combination treatments, increasing demand for non-invasive procedures, the growing use of teledermatology, broader applications of photodynamic therapy, increased awareness of cosmetic outcomes, the development of targeted biologic treatments, rising healthcare investment in emerging markets, and a stronger focus on early detection and prevention. Major trends during this period include AI-driven diagnostic tools, machine learning for lesion analysis, advancements in photodynamic therapy, wearable UV monitoring devices, nanotechnology-based drug delivery systems, 3D imaging for personalized treatments, portable home-based phototherapy devices, biosensors for early detection, automated lesion classification software, and hydrogel-based therapeutic systems.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077

What Are the Key Market Innovations in theActinic Keratosis Market Over the Coming Years?

In the actinic keratosis market, major players are focusing on topical ointments to treat precancerous lesions and improve patient compliance with shorter treatment durations. A key example is Klisyri (tirbanibulin), developed by Almirall SA, a Spain-based biopharmaceutical company. In June 2024, Klisyri received FDA approval for its expanded use on up to 100 cm² of affected skin, offering a more targeted treatment for actinic keratosis on the face or scalp.

Who Are the Top Companies Driving Innovation and Growth in theActinic Keratosis Market?

Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Key Market Segments Comprise the Actinic Keratosis Market and Drive Its Revenue Growth?

The actinic keratosis market covered in this report is segmented –

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

3) By End-User: Hospitals, Dermatology Clinics, Spas And Rejuvenation Centers, Homecare Settings, Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac, Ingenol Mebutate, Retinoids

2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication, Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy, Chemical Peels, Combination Therapies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp

Which Regions Are Emerging as Leaders in the Actinic Keratosis Market?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Actinic Keratosis Market 2025, By The Business Research Company:

Pediatric Bladder Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-bladder-treatment-global-market-report

Pediatric Imaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the actinic keratosis market right now?

The growth of the actinic keratosis market has been consistent in past years. It’s projected to expand from 2024’s $7.95 billion to $8.44 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.1%. The historical growth can be accredited to several factors such as greater exposure to UV radiation, an aging demographic, heightened awareness of skin cancer, the rising incidence of actinic keratosis, improvements in healthcare infrastructure, increased disposable incomes, beneficial government policies, and the growing emphasis on preventive skincare.

How fast Is the actinic keratosis market expected to grow, and what’s its future value?

The market for actinic keratosis is predicted to experience a significant surge in its size in the upcoming years, expanding to a worth of $10.58 billion in 2029 with a CAGR of 7.4%. The growth projected for this period can be credited to a variety of factors including the introduction of ground-breaking therapies, progress in AI-supported diagnostic instruments, growing use of combination therapies, an increase in the demand for non-invasive operations, and the broadening use of tele dermatology. Other contributing factors include the widespread use of photodynamic therapy, heightened awareness about cosmetic results, evolution of targeted biological treatments, improved healthcare spending in developing markets and an increased emphasis on early detection and prevention. A variety of trends are expected to shape the forecast period, including AI-based diagnostic instruments, machine learning for lesion analysis, sophisticated photodynamic therapy systems, wearable UV monitoring gadgets, nanotechnology for drug delivery, 3D imaging for individualized treatments, portable phototherapy devices for home use, early detection biosensors, software for automated lesion classification, and hydrogel-based therapeutic systems.

Get your actinic keratosis market report here!

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

What are the leading drivers of growth in the actinic keratosis market?

The surge in instances of extreme sunburns is anticipated to fuel the expansion of the actinic keratosis market. Severe sunburns, characterized by intense skin burns due to overexposure to ultraviolet (UV) radiation, evoke redness, pain, swelling and occasionally blistering. Prolonged exposure to UV radiation, inadequate sun protection measures, heightened outdoor activities during peak UV hours, and escalating temperatures due to climate change are few of the key factors sparking sunburns. Actinic keratosis is a consequence of sunburns, where the DNA in skin cells is damaged by UV radiation, triggering mutations that interfere with regular cell functions, culminating in the formation of precancerous lesions, especially with repeated or sustained sun exposure. For example, as per Melanoma Focus, a charity based in the UK, 201 hospital admissions resulted from sunburn in 2022-23, comprising 89 children and 25 infants under a year old. The charity also discovered that 66% of UK adults from 16 to 65 recalled being sunburned as children, with 65% suffering from blistering due to severe sunburn at least once. This figure escalates to 77% for individuals with light, pale, or white skin. Consequently, the escalating instances of severe sunburns are contributing to the growth of the actinic keratosis market.

What are the key segments defining the actinic keratosis market?

The actinic keratosis market covered in this report is segmented –

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

3) By End-User: Hospitals, Dermatology Clinics, Spas And Rejuvenation Centers, Homecare Settings, Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac, Ingenol Mebutate, Retinoids

2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication, Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy, Chemical Peels, Combination Therapies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

Who are the key players steering the development of the actinic keratosis market?

Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.

What are the key trends shaping the future of the actinic keratosis market?

Prominent organizations in the actinic keratosis market are concentrating their efforts on the creation of topical solutions to efficiently address and eradicate precancerous growths, decrease the likelihood of reoccurrence and increase patient adherence through reduced treatment timeframes and enhanced safety parameters. These topical solutions are medicinal creams or gels that are directly applied to the impacted skin containing the active element tirbanibulin, which targets defective keratinocytes to address precancerous growths. For example, in June 2024, Almirall SA, a major biopharmaceutical organization in Spain, received the green light from the US Food and Drug Administration (FDA) for supplemental new drug application (sNDA) to broaden the application scope of its medication, Klisyri, to cover an area of 100 cm2. The treatment Klisyri (tirbanibulin) 1% ointment impedes the multiplication of abnormal keratinocytes, effectively shrinking the precancerous lesion’s quantity and size for treating actinic keratosis (AK) on the face or scalp.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077

Which regions are most influential in expanding the actinic keratosis market?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Pediatric Bladder Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-bladder-treatment-global-market-report

Pediatric Imaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted CAGR for the Actinic Keratosis Market Over the Forecast Period of 2025 to 2034?

Recent years have seen a consistent expansion in the actinic keratosis market size, moving from $7.95 billion in 2024 to an expected $8.44 billion in 2025, representing a compound annual growth rate (CAGR) of 6.1%. This upward trend during the historical period can be linked to factors such as an increase in UV radiation exposure, an aging demographic, heightened awareness around skin cancer, a rising incidence of actinic keratosis, the growth in healthcare infrastructure, larger disposable incomes, backing from government schemes, and a heightened emphasis on preemptive skincare.

In the ensuing years, the market size of actinic keratosis is anticipated to experience a significant increase, expanding to a value of $10.58 billion in 2029, with an annual compound growth rate of 7.4%. The rise during the projection period can be attributed to several factors, such as the introduction of new therapies, advancements in AI-enabled diagnostic tools, an increase in the adoption of combination treatments, and the growing demand for non-invasive procedures. The rise of tele dermatology, wider use of photodynamic therapy, increased cognizance of cosmetic results, the creation of targeted biologic treatments, and increased health investments in emerging markets along with an emphasis on early detection and prevention also contribute to this growth. The industry also expects to witness trends like AI-powered diagnostic instruments, machine learning for lesion examination, sophisticated photodynamic therapy systems, wearable UV monitoring devices, nanotechnology in drug delivery, 3D imaging for customized treatments, portable phototherapy devices for home-usage, early detection biosensors, software for automatic lesion classification and therapeutic systems based on hydrogel.

What Factors Are Propelling the Growth of the Actinic Keratosis Market from 2025 to 2034?

The actinic keratosis market is expected to grow due to the rise in severe sunburn cases. Severe sunburns, characterized by intense skin burns caused by excess exposure to ultraviolet (UV) radiation, result in redness, discomfort, swelling, and occasionally blisters. These sunburns occur due to extended exposure to UV radiation, inadequate sun protection, increased outdoor activities during peak UV radiation hours, and climbing temperatures due to climate change. Actinic keratosis arises when sunburns damage the DNA in skin cells via UV radiation, causing mutations that disrupt normal cell functioning and leading to the generation of precancerous lesions, especially with recurrent or long-term sun exposure. For instance, Melanoma Focus, a UK-based charity, reported in May 2024 that in 2022-23, 201 hospital admissions were due to sunburn, which included 89 children and 25 babies under a year old. The charity discovered that 66% of UK adults aged 16-65 recalled being sunburned in their childhood and 65% of them had experienced a severe sunburn with blisters at least once. This statistic rose to 77% for individuals with light, pale, or white skin. Consequently, the growth of the actinic keratosis market is being fueled by the increasing number of severe sunburn cases.

Explore Comprehensive Insights Into The Global Actinic Keratosis Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

Who are the key firms paving the way for growth in the Actinic Keratosis market?

Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.

What Key Trends Are Currently Impacting the Actinic Keratosis Market’s Development?

Top players in the actinic keratosis market are channeling their efforts towards the invention of topical ointments that can better target and obliterate precancerous lesions, lower relapse instances, and improve patient adherence with dwindled treatment times and superior safety measures. These topical ointments are medicated creams or gels that have an active ingredient such as tirbanibulin which is formulated to target abnormal keratinocytes for the successful treatment of precancerous lesions. For example, Almirall SA, a biopharmaceutical firm based in Spain, was approved by the US Food and Drug Administration (FDA) in June 2024 for its supplemental new drug application (sNDA) to broaden the use of its drug, Klisyri, to an area of upto 100 cm2. Klisyri (tirbanibulin) 1% ointment inhibits microtubules and is specifically designed to hamper the growth of abnormal keratinocytes which eventually results in the reduction of both the number and size of precancerous lesions, thus benefiting the treatment procedure of actinic keratosis (AK) on the face or scalp.

Secure Your Global Actinic Keratosis Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Actinic Keratosis Market?

The actinic keratosis market covered in this report is segmented –

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types

2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

3) By End-User: Hospitals, Dermatology Clinics, Spas And Rejuvenation Centers, Homecare Settings, Other End-Users

Subsegments:

1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac, Ingenol Mebutate, Retinoids

2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication, Excision

3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy

4) By Other Treatment Types: Laser Therapy, Chemical Peels, Combination Therapies

Which Geographical Regions Are Pioneering Growth in the Actinic Keratosis Market?

North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Do Experts Define the Scope of the Actinic Keratosis Market?

Actinic keratosis (AK), also known as solar keratosis, is a common precancerous skin condition that occurs due to prolonged exposure to ultraviolet (UV) radiation from the sun or artificial sources leading to rough, scaly or crusty patches on sun-exposed areas of the skin such as the face, scalp, hands and arms. It is considered an early stage of squamous cell carcinoma (SCC) and requires treatment to prevent progression. Regular skin checks and protection from sun exposure are essential for managing and preventing the development of actinic keratosis.

Browse Through More Similar Reports By The Business Research Company:

Pediatric Bladder Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-bladder-treatment-global-market-report

Pediatric Imaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: